Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Ltd has updated its corporate governance statement for the financial year ending June 30, 2024, ensuring compliance with ASX Corporate Governance Council recommendations and outlining the roles and responsibilities of its board and management. The complete statement is accessible on their website, verified by the board and approved by Emma Waldon, Company Secretary on August 28, 2024. Argenica has adhered to key governance principles, including director appointments, agreements and company secretary accountability, with details available online for investors.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
